
Revolutionary Weight Loss Drug Enhances Energy and Curbs Appetite Safely
Researchers at the University of Copenhagen have discovered that activating the Neurokinin 2 Receptor (NK2R) can safely reduce weight and reverse diabetes by increasing energy expenditure and reducing appetite without side effects. This breakthrough could lead to more effective treatments for obesity and type 2 diabetes, benefiting millions worldwide. The study, published in Nature, shows promising results in both mice and non-human primates, and the University holds patent rights for this potential new therapy.


